Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 29 million
▲ 2% vs 2024
Profit
Growing€ 625,092
▲ 159% vs 2024
Debts
Low€ 9.7 million
▼ 11% vs 2024
S.A. Laboratoires Pharmaceutiques Trenker from Nivelles, company number BE0423960076, closed financial year 2025 with a result of € 625,092 after tax. For that financial year S.A. Laboratoires Pharmaceutiques Trenker recorded revenue of € 29 million and equity of € 6.4 million. Compared with financial year 2024, the result moved from € 241,517 to € 625,092. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
What happened at S.A. Laboratoires Pharmaceutiques Trenker?
What happened at S.A. Laboratoires Pharmaceutiques Trenker in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- FOXFIN BV SRL stepped down as director. NBB
- MEDECA BV SRL stepped down as director. NBB
- ERUDITE BV SRL stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 625,092 (▲ 159% vs 2024). Source: NBB ↗
- FOXFIN BV SRL became a director. NBB
- MEDECA BV SRL became a director. NBB
- ERUDITE BV SRL became a director. NBB
- New establishment in Nivelles. KBO
In short
From € 993,098 profit in 2021 to € 625,092 profit in 2025.
Paid € 254,684 in corporate taxes since 2021.
Best year ever: 2021, with € 993,098 profit.
Paid out € 1.8 million in dividends to the owners in total.
A new publication or filing at S.A. Laboratoires Pharmaceutiques Trenker? We notify you, reason included.
Follow S.A. Laboratoires Pharmaceutiques TrenkerNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of TRENKER NUTRITION SCRL itself.
Directors
According to the 2025 annual accounts
Director · represented by Barbara De Saedeleer
Also active at: RECTICEL, T.DIFFUSION, UNICUM TRADE BOTANICALS +7 more
since 2024 · until 2030
Director · represented by Charles Declerck
Also active at: T.DIFFUSION, ROBINWOOD, NUTRIPHYT +4 more
since 2024 · until 2030
Director · represented by Louis Declerck
Also active at: T.DIFFUSION, ROBINWOOD, NUTRIPHYT +4 more
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Avenue Thomas Edison 32
1402 Nivelles
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Details
- Company number
- 0423.960.076
- VAT number
- BE 0423.960.076
- Registered office
- Avenue Thomas Edison 32, 1402 Nivelles
- Names & denominations
- S.A. Laboratoires Pharmaceutiques Trenker · N.V. Farmaceutische Laboratoria Trenker
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 21 January 1983
- Peppol
- Active · Active since 8 Oct 2025
- Contact
- trenker.be info@trenker.be
- Activities · NACE
Vervaardiging van geneesmiddelen
Vervaardiging van farmaceutische grondstoffen